NATERA, INC. Proceeds from (Repurchase of) Equity
NATERA, INC. (NTRA) reported Proceeds from (Repurchase of) Equity of $970.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepurchaseOfEquity · last filed 2018-03-15
- NATERA, INC. proceeds from (repurchase of) equity for the quarter ending 2015-12-31 was -$627.00K, a 135.30% decline year-over-year.
- NATERA, INC. proceeds from (repurchase of) equity for the quarter ending 2015-09-30 was $180.31M.
- NATERA, INC. proceeds from (repurchase of) equity for the quarter ending 2015-06-30 was $209.00K.
- NATERA, INC. proceeds from (repurchase of) equity for the quarter ending 2015-03-31 was $106.00K.
- NATERA, INC. proceeds from (repurchase of) equity for fiscal 2015 was $180.00M, a 105782.94% increase from fiscal 2014.
- NATERA, INC. proceeds from (repurchase of) equity for fiscal 2014 was $170.00K, a 34.36% decline from fiscal 2013.
- NATERA, INC. proceeds from (repurchase of) equity for fiscal 2013 was $259.00K.
| Period end | Proceeds from (Repurchase of) Equity 3 month | Proceeds from (Repurchase of) Equity 6 month | Proceeds from (Repurchase of) Equity 9 month | Proceeds from (Repurchase of) Equity 12 month |
|---|---|---|---|---|
| 2016-06-30 | $970.00K 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | -$627.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $179.69M derived: sum of 2 quarters · filed 2018-03-15 | $179.90M derived: sum of 3 quarters · filed 2018-03-15 | $180.00M 10-K · filed 2018-03-15 |
| 2015-09-30 | $180.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $180.52M derived: sum of 2 quarters · filed 2016-08-11 | $180.63M 10-Q · filed 2015-11-13 | $182.40M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $315.00K 10-Q · filed 2016-08-11 | $2.09M derived: sum of 3 quarters · filed 2017-03-16 | |
| 2015-03-31 | $106.00K 10-Q · filed 2016-05-13 | $1.88M derived: sum of 2 quarters · filed 2017-03-16 | ||
| 2014-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $170.00K 10-K · filed 2017-03-16 | ||
| 2014-09-30 | -$1.61M 10-Q · filed 2015-11-13 | |||
| 2013-12-31 | $259.00K 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |